Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
10.11
-0.07 (-0.69%)
Nov 22, 2024, 4:00 PM EST - Market closed
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.11 billion as of November 22, 2024. Its market cap has increased by 412.35% in one year.
Market Cap
1.11B
Enterprise Value
1.17B
1-Year Change
412.35%
Ranking
Category
Stock Price
$10.11
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $1.11B, an increase of 87.77%. That is a compound annual growth rate of 7.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.24B | 589.78% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artivion | 1.18B |
| Rocket Pharmaceuticals | 1.17B |
| Pharvaris | 1.14B |
| Avadel Pharmaceuticals | 1.12B |
| Aveanna Healthcare Holdings | 1.12B |
| Phreesia | 1.10B |
| ANI Pharmaceuticals | 1.09B |
| Applied Therapeutics | 1.08B |